Velo-cardio-facial syndrome.
Shprintzen RJ, Higgins AM, Antshel K, Fremont W, Roizen N, Kates W.
Curr Opin Pediatr. 2005 Dec;17(6):725-30. doi: 10.1097/01.mop.0000184465.73833.0b.
Annotation: velo-cardio-facial syndrome.
Murphy KC.
J Child Psychol Psychiatry. 2005 Jun;46(6):563-71. doi: 10.1111/j.1469-7610.2005.00408.x.
Velo-cardio-facial syndrome: 30 Years of study.
Shprintzen RJ.
Dev Disabil Res Rev. 2008;14(1):3-10. doi: 10.1002/ddrr.2.
Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).
McDonald-McGinn DM, Sullivan KE.
Medicine (Baltimore). 2011 Jan;90(1):1-18. doi: 10.1097/MD.0b013e3182060469.
The facial phenotype of the velo-cardio-facial syndrome.
Butts SC.
Int J Pediatr Otorhinolaryngol. 2009 Mar;73(3):343-50. doi: 10.1016/j.ijporl.2008.10.011. Epub 2008 Dec 4.
Velo-cardio-facial syndrome: the pediatric otolaryngologist's perspective.
Butts SC, Tatum SA 3rd, Mortelliti AJ, Shprintzen RJ.
Curr Opin Otolaryngol Head Neck Surg. 2005 Dec;13(6):371-5. doi: 10.1097/01.moo.0000186203.53214.ac.
Chromosome 22q11.2 Deletion (DiGeorge Syndrome): Immunologic Features, Diagnosis, and Management.
Biggs SE, Gilchrist B, May KR.
Curr Allergy Asthma Rep. 2023 Apr;23(4):213-222. doi: 10.1007/s11882-023-01071-4. Epub 2023 Mar 10.
The neurocognitive phenotype in velo-cardio-facial syndrome: a developmental perspective.
Antshel KM, Fremont W, Kates WR.
Dev Disabil Res Rev. 2008;14(1):43-51. doi: 10.1002/ddrr.7.
The velo-cardio-facial syndrome: the otorhinolaryngeal manifestations and implications.
Vantrappen G, Rommel N, Cremers CW, Devriendt K, Frijns JP.
Int J Pediatr Otorhinolaryngol. 1998 Oct 2;45(2):133-41. doi: 10.1016/s0165-5876(98)00067-6.
The behavioural phenotype in velo-cardio-facial syndrome (VCFS): from infancy to adolescence.
Swillen A, Devriendt K, Legius E, Prinzie P, Vogels A, Ghesquière P, Fryns JP.
Genet Couns. 1999;10(1):79-88.
